HER-2 Targeted Drugs for Breast Cancer Market Report

Global and China HER-2 Targeted Drugs for Breast Cancer Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 26, 2022
  • PAGES：185
  • REPORT CODE：GMM1409848
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the HER-2 Targeted Drugs for Breast Cancer industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Puma Biotechnology

    • Hengrui Medicine

    • Hetero Drugs

    • Roche

    • CANbridge

    • Novartis

    • GlaxoSmithKline

    • Beacon Pharmaceuticals Limited

    • Chugai Pharmaceutical

    • Pfizer

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Trastuzumab

    • Pertuzumab

    • Lapatinib

    • Neratinib

    • Trastuzumab Emtansine

    • Pyrotinib

    • Other

    Application:

    • Hospital

    • Clinic

    • Drug Center

    • Other

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 HER-2 Targeted Drugs for Breast Cancer Industry Overview

      • 1.1.1 HER-2 Targeted Drugs for Breast Cancer Market Scope and Market Segments

      • 1.1.2 HER-2 Targeted Drugs for Breast Cancer Industry Characteristics

      • 1.1.3 Global and China HER-2 Targeted Drugs for Breast Cancer Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China HER-2 Targeted Drugs for Breast Cancer Production Value and Growth Rate (2017-2028)

    • 1.2 Global HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Trastuzumab

      • 1.2.2 Pertuzumab

      • 1.2.3 Lapatinib

      • 1.2.4 Neratinib

      • 1.2.5 Trastuzumab Emtansine

      • 1.2.6 Pyrotinib

      • 1.2.7 Other

    • 1.3 Global HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital

      • 1.3.2 Clinic

      • 1.3.3 Drug Center

      • 1.3.4 Other

    • 1.4 Market Analysis by Region

      • 1.4.1 North America HER-2 Targeted Drugs for Breast Cancer Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe HER-2 Targeted Drugs for Breast Cancer Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC HER-2 Targeted Drugs for Breast Cancer Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa HER-2 Targeted Drugs for Breast Cancer Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global HER-2 Targeted Drugs for Breast Cancer Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global HER-2 Targeted Drugs for Breast Cancer Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China HER-2 Targeted Drugs for Breast Cancer Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China HER-2 Targeted Drugs for Breast Cancer Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global HER-2 Targeted Drugs for Breast Cancer Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 HER-2 Targeted Drugs for Breast Cancer Industry Porter's Five Forces Model Analysis

      • 2.2.3 HER-2 Targeted Drugs for Breast Cancer Industry PEST Analysis

    • 2.3 HER-2 Targeted Drugs for Breast Cancer Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 HER-2 Targeted Drugs for Breast Cancer Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on HER-2 Targeted Drugs for Breast Cancer Industry

    Chapter 3 Global and China HER-2 Targeted Drugs for Breast Cancer Market, by Manufacturer

    • 3.1 Global and China HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China HER-2 Targeted Drugs for Breast Cancer Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China HER-2 Targeted Drugs for Breast Cancer Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China HER-2 Targeted Drugs for Breast Cancer Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China HER-2 Targeted Drugs for Breast Cancer Market Top 3 Players

    Chapter 4 Global and China HER-2 Targeted Drugs for Breast Cancer Market, by Type (2017-2028)

    • 4.1 HER-2 Targeted Drugs for Breast Cancer Market Trend, by Type

    • 4.2 Global HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global HER-2 Targeted Drugs for Breast Cancer Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global HER-2 Targeted Drugs for Breast Cancer Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global HER-2 Targeted Drugs for Breast Cancer Price Trend, by Type (2017-2028)

    • 4.3 China HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China HER-2 Targeted Drugs for Breast Cancer Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China HER-2 Targeted Drugs for Breast Cancer Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China HER-2 Targeted Drugs for Breast Cancer Price Trend, by Type (2017-2028)

    Chapter 5 Global and China HER-2 Targeted Drugs for Breast Cancer Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global HER-2 Targeted Drugs for Breast Cancer Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global HER-2 Targeted Drugs for Breast Cancer Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China HER-2 Targeted Drugs for Breast Cancer Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China HER-2 Targeted Drugs for Breast Cancer Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global HER-2 Targeted Drugs for Breast Cancer Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China HER-2 Targeted Drugs for Breast Cancer Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America HER-2 Targeted Drugs for Breast Cancer Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe HER-2 Targeted Drugs for Breast Cancer Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC HER-2 Targeted Drugs for Breast Cancer Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa HER-2 Targeted Drugs for Breast Cancer Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America HER-2 Targeted Drugs for Breast Cancer Market Analysis

    • 7.1 North America HER-2 Targeted Drugs for Breast Cancer Market, by Type

    • 7.2 North America HER-2 Targeted Drugs for Breast Cancer Market, by Application

    • 7.3 North America HER-2 Targeted Drugs for Breast Cancer Market Analysis and Forecast, by Country

      • 7.3.1 United States HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe HER-2 Targeted Drugs for Breast Cancer Market Analysis

    • 8.1 Europe HER-2 Targeted Drugs for Breast Cancer Market, by Type

    • 8.2 Europe HER-2 Targeted Drugs for Breast Cancer Market, by Application

    • 8.3 Europe HER-2 Targeted Drugs for Breast Cancer Market Analysis and Forecast, by Country

      • 8.3.1 Germany HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC HER-2 Targeted Drugs for Breast Cancer Market Analysis

    • 9.1 APAC HER-2 Targeted Drugs for Breast Cancer Market, by Type

    • 9.2 APAC HER-2 Targeted Drugs for Breast Cancer Market, by Application

    • 9.3 APAC HER-2 Targeted Drugs for Breast Cancer Market Analysis and Forecast, by Country

      • 9.3.1 China HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa HER-2 Targeted Drugs for Breast Cancer Market Analysis

    • 10.1 Latin America, Middle East and Africa HER-2 Targeted Drugs for Breast Cancer Market, by Type

    • 10.2 Latin America, Middle East and Africa HER-2 Targeted Drugs for Breast Cancer Market, by Application

    • 10.3 Latin America, Middle East and Africa HER-2 Targeted Drugs for Breast Cancer Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina HER-2 Targeted Drugs for Breast Cancer Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China HER-2 Targeted Drugs for Breast Cancer Company Profiles

      • 11.1 Puma Biotechnology

        • 11.1.1 Puma Biotechnology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Puma Biotechnology HER-2 Targeted Drugs for Breast Cancer Product Profiles, Application and Specification

        • 11.1.3 Puma Biotechnology HER-2 Targeted Drugs for Breast Cancer Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Hengrui Medicine

        • 11.2.1 Hengrui Medicine Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Hengrui Medicine HER-2 Targeted Drugs for Breast Cancer Product Profiles, Application and Specification

        • 11.2.3 Hengrui Medicine HER-2 Targeted Drugs for Breast Cancer Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Hetero Drugs

        • 11.3.1 Hetero Drugs Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Hetero Drugs HER-2 Targeted Drugs for Breast Cancer Product Profiles, Application and Specification

        • 11.3.3 Hetero Drugs HER-2 Targeted Drugs for Breast Cancer Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Roche

        • 11.4.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Roche HER-2 Targeted Drugs for Breast Cancer Product Profiles, Application and Specification

        • 11.4.3 Roche HER-2 Targeted Drugs for Breast Cancer Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 CANbridge

        • 11.5.1 CANbridge Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 CANbridge HER-2 Targeted Drugs for Breast Cancer Product Profiles, Application and Specification

        • 11.5.3 CANbridge HER-2 Targeted Drugs for Breast Cancer Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Novartis

        • 11.6.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Novartis HER-2 Targeted Drugs for Breast Cancer Product Profiles, Application and Specification

        • 11.6.3 Novartis HER-2 Targeted Drugs for Breast Cancer Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 GlaxoSmithKline

        • 11.7.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 GlaxoSmithKline HER-2 Targeted Drugs for Breast Cancer Product Profiles, Application and Specification

        • 11.7.3 GlaxoSmithKline HER-2 Targeted Drugs for Breast Cancer Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Beacon Pharmaceuticals Limited

        • 11.8.1 Beacon Pharmaceuticals Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Beacon Pharmaceuticals Limited HER-2 Targeted Drugs for Breast Cancer Product Profiles, Application and Specification

        • 11.8.3 Beacon Pharmaceuticals Limited HER-2 Targeted Drugs for Breast Cancer Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Chugai Pharmaceutical

        • 11.9.1 Chugai Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Chugai Pharmaceutical HER-2 Targeted Drugs for Breast Cancer Product Profiles, Application and Specification

        • 11.9.3 Chugai Pharmaceutical HER-2 Targeted Drugs for Breast Cancer Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Pfizer

        • 11.10.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Pfizer HER-2 Targeted Drugs for Breast Cancer Product Profiles, Application and Specification

        • 11.10.3 Pfizer HER-2 Targeted Drugs for Breast Cancer Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 HER-2 Targeted Drugs for Breast Cancer Industry Investment Prospect and Risk Assessment

    • 12.1 HER-2 Targeted Drugs for Breast Cancer Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 HER-2 Targeted Drugs for Breast Cancer Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global HER-2 Targeted Drugs for Breast Cancer Sales Volume and Growth Rate (2017-2028)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Sales Volume and Growth Rate (2017-2028)

    • Figure Global HER-2 Targeted Drugs for Breast Cancer Production Value and Growth Rate (2017-2028)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Production Value and Growth Rate (2017-2028)

    • Figure Global HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Trastuzumab (2017-2028)

    • Figure Global HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Pertuzumab (2017-2028)

    • Figure Global HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Lapatinib (2017-2028)

    • Figure Global HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Neratinib (2017-2028)

    • Figure Global HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Trastuzumab Emtansine (2017-2028)

    • Figure Global HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Pyrotinib (2017-2028)

    • Figure Global HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Other (2017-2028)

    • Figure Global HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Clinic (2017-2028)

    • Figure Global HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Drug Center (2017-2028)

    • Figure Global HER-2 Targeted Drugs for Breast Cancer Market Size and Growth Rate of Other (2017-2028)

    • Figure North America HER-2 Targeted Drugs for Breast Cancer Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe HER-2 Targeted Drugs for Breast Cancer Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC HER-2 Targeted Drugs for Breast Cancer Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa HER-2 Targeted Drugs for Breast Cancer Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global HER-2 Targeted Drugs for Breast Cancer Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China HER-2 Targeted Drugs for Breast Cancer Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China HER-2 Targeted Drugs for Breast Cancer Sales Value, by Manufacturer (2021&2022)

    • Table Global and China HER-2 Targeted Drugs for Breast Cancer Market Share, by Manufacturer (2021&2022)

    • Figure Global and China HER-2 Targeted Drugs for Breast Cancer Market Share, by Manufacturer in 2021

    • Figure Global and China HER-2 Targeted Drugs for Breast Cancer Market Share, by Manufacturer in 2022

    • Table Global HER-2 Targeted Drugs for Breast Cancer Sales Volume, by Type (2017-2028)

    • Table Global HER-2 Targeted Drugs for Breast Cancer Sales Volume Share, by Type (2017-2028)

    • Figure Global HER-2 Targeted Drugs for Breast Cancer Sales Volume Share, by Type (2017-2028)

    • Table Global HER-2 Targeted Drugs for Breast Cancer Sales Value, by Type (2017-2028)

    • Table Global HER-2 Targeted Drugs for Breast Cancer Sales Value Share, by Type (2017-2028)

    • Figure Global HER-2 Targeted Drugs for Breast Cancer Price Trend, by Type (2017-2028)

    • Table China HER-2 Targeted Drugs for Breast Cancer Sales Volume, by Type (2017-2028)

    • Table China HER-2 Targeted Drugs for Breast Cancer Sales Volume Share, by Type (2017-2028)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Sales Volume Share, by Type (2017-2028)

    • Table China HER-2 Targeted Drugs for Breast Cancer Sales Value, by Type (2017-2028)

    • Table China HER-2 Targeted Drugs for Breast Cancer Sales Value Share, by Type (2017-2028)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Price Trend, by Type (2017-2028)

    • Table Global HER-2 Targeted Drugs for Breast Cancer Sales Volume, by Application (2017-2028)

    • Table Global HER-2 Targeted Drugs for Breast Cancer Sales Volume Share, by Application (2017-2028)

    • Figure Global HER-2 Targeted Drugs for Breast Cancer Sales Volume Share, by Application (2017-2028)

    • Table Global HER-2 Targeted Drugs for Breast Cancer Sales Value, by Application (2017-2028)

    • Table Global HER-2 Targeted Drugs for Breast Cancer Sales Value Share, by Application (2017-2028)

    • Figure Global HER-2 Targeted Drugs for Breast Cancer Sales Value Share, by Application (2017-2028)

    • Table China HER-2 Targeted Drugs for Breast Cancer Sales Volume, by Application (2017-2028)

    • Table China HER-2 Targeted Drugs for Breast Cancer Sales Volume Share, by Application (2017-2028)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Sales Volume Share, by Application (2017-2028)

    • Table China HER-2 Targeted Drugs for Breast Cancer Sales Value, by Application (2017-2028)

    • Table China HER-2 Targeted Drugs for Breast Cancer Sales Value Share, by Application (2017-2028)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Sales Value Share, by Application (2017-2028)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Production, Import, Consumption and Export (2017-2022)

    • Figure North America HER-2 Targeted Drugs for Breast Cancer Production, Import, Consumption and Export (2017-2022)

    • Figure Europe HER-2 Targeted Drugs for Breast Cancer Production, Import, Consumption and Export (2017-2022)

    • Figure APAC HER-2 Targeted Drugs for Breast Cancer Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa HER-2 Targeted Drugs for Breast Cancer Production, Import, Consumption and Export (2017-2022)

    • Table North America HER-2 Targeted Drugs for Breast Cancer Sales Volume, by Type (2017-2028)

    • Table North America HER-2 Targeted Drugs for Breast Cancer Sales Volume Share, by Type (2017-2028)

    • Figure North America HER-2 Targeted Drugs for Breast Cancer Sales Volume Share, by Type (2017-2028)

    • Table North America HER-2 Targeted Drugs for Breast Cancer Sales Volume, by Application (2017-2028)

    • Table North America HER-2 Targeted Drugs for Breast Cancer Sales Volume Share, by Application (2017-2028)

    • Figure North America HER-2 Targeted Drugs for Breast Cancer Sales Volume Share, by Application (2017-2028)

    • Figure United States HER-2 Targeted Drugs for Breast Cancer Sales Volume and Growth Rate (2017-2028)

    • Figure United States HER-2 Targeted Drugs for Breast Cancer Sales Value and Growth Rate (2017-2028)

    • Figure Canada HER-2 Targeted Drugs for Breast Cancer Sales Volume and Growth Rate (2017-2028)

    • Figure Canada HER-2 Targeted Drugs for Breast Cancer Sales Value and Growth Rate (2017-2028)

    • Figure Mexico HER-2 Targeted Drugs for Breast Cancer Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico HER-2 Targeted Drugs for Breast Cancer Sales Value and Growth Rate (2017-2028)

    • Table Europe HER-2 Targeted Drugs for Breast Cancer Sales Volume, by Type (2017-2028)

    • Table Europe HER-2 Targeted Drugs for Breast Cancer Sales Volume Share, by Type (2017-2028)

    • Figure Europe HER-2 Targeted Drugs for Breast Cancer Sales Volume Share, by Type (2017-2028)

    • Table Europe HER-2 Targeted Drugs for Breast Cancer Sales Volume, by Application (2017-2028)

    • Table Europe HER-2 Targeted Drugs for Breast Cancer Sales Volume Share, by Application (2017-2028)

    • Figure Europe HER-2 Targeted Drugs for Breast Cancer Sales Volume Share, by Application (2017-2028)

    • Figure Germany HER-2 Targeted Drugs for Breast Cancer Sales Volume and Growth Rate (2017-2028)

    • Figure Germany HER-2 Targeted Drugs for Breast Cancer Sales Value and Growth Rate (2017-2028)

    • Figure UK HER-2 Targeted Drugs for Breast Cancer Sales Volume and Growth Rate (2017-2028)

    • Figure UK HER-2 Targeted Drugs for Breast Cancer Sales Value and Growth Rate (2017-2028)

    • Figure France HER-2 Targeted Drugs for Breast Cancer Sales Volume and Growth Rate (2017-2028)

    • Figure France HER-2 Targeted Drugs for Breast Cancer Sales Value and Growth Rate (2017-2028)

    • Figure Italy HER-2 Targeted Drugs for Breast Cancer Sales Volume and Growth Rate (2017-2028)

    • Figure Italy HER-2 Targeted Drugs for Breast Cancer Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries HER-2 Targeted Drugs for Breast Cancer Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries HER-2 Targeted Drugs for Breast Cancer Sales Value and Growth Rate (2017-2028)

    • Figure Spain HER-2 Targeted Drugs for Breast Cancer Sales Volume and Growth Rate (2017-2028)

    • Figure Spain HER-2 Targeted Drugs for Breast Cancer Sales Value and Growth Rate (2017-2028)

    • Figure Belgium HER-2 Targeted Drugs for Breast Cancer Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium HER-2 Targeted Drugs for Breast Cancer Sales Value and Growth Rate (2017-2028)

    • Figure Poland HER-2 Targeted Drugs for Breast Cancer Sales Volume and Growth Rate (2017-2028)

    • Figure Poland HER-2 Targeted Drugs for Breast Cancer Sales Value and Growth Rate (2017-2028)

    • Figure Russia HER-2 Targeted Drugs for Breast Cancer Sales Volume and Growth Rate (2017-2028)

    • Figure Russia HER-2 Targeted Drugs for Breast Cancer Sales Value and Growth Rate (2017-2028)

    • Figure Turkey HER-2 Targeted Drugs for Breast Cancer Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey HER-2 Targeted Drugs for Breast Cancer Sales Value and Growth Rate (2017-2028)

    • Table APAC HER-2 Targeted Drugs for Breast Cancer Sales Volume, by Type (2017-2028)

    • Table APAC HER-2 Targeted Drugs for Breast Cancer Sales Volume Share, by Type (2017-2028)

    • Figure APAC HER-2 Targeted Drugs for Breast Cancer Sales Volume Share, by Type (2017-2028)

    • Table APAC HER-2 Targeted Drugs for Breast Cancer Sales Volume, by Application (2017-2028)

    • Table APAC HER-2 Targeted Drugs for Breast Cancer Sales Volume Share, by Application (2017-2028)

    • Figure APAC HER-2 Targeted Drugs for Breast Cancer Sales Volume Share, by Application (2017-2028)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Sales Volume and Growth Rate (2017-2028)

    • Figure China HER-2 Targeted Drugs for Breast Cancer Sales Value and Growth Rate (2017-2028)

    • Figure Japan HER-2 Targeted Drugs for Breast Cancer Sales Volume and Growth Rate (2017-2028)

    • Figure Japan HER-2 Targeted Drugs for Breast Cancer Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand HER-2 Targeted Drugs for Breast Cancer Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand HER-2 Targeted Drugs for Breast Cancer Sales Value and Growth Rate (2017-2028)

    • Figure India HER-2 Targeted Drugs for Breast Cancer Sales Volume and Growth Rate (2017-2028)

    • Figure India HER-2 Targeted Drugs for Breast Cancer Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries HER-2 Targeted Drugs for Breast Cancer Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries HER-2 Targeted Drugs for Breast Cancer Sales Value and Growth Rate (2017-2028)

    • Figure South Korea HER-2 Targeted Drugs for Breast Cancer Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea HER-2 Targeted Drugs for Breast Cancer Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa HER-2 Targeted Drugs for Breast Cancer Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa HER-2 Targeted Drugs for Breast Cancer Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa HER-2 Targeted Drugs for Breast Cancer Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa HER-2 Targeted Drugs for Breast Cancer Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa HER-2 Targeted Drugs for Breast Cancer Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa HER-2 Targeted Drugs for Breast Cancer Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries HER-2 Targeted Drugs for Breast Cancer Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries HER-2 Targeted Drugs for Breast Cancer Sales Value and Growth Rate (2017-2028)

    • Figure Brazil HER-2 Targeted Drugs for Breast Cancer Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil HER-2 Targeted Drugs for Breast Cancer Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria HER-2 Targeted Drugs for Breast Cancer Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria HER-2 Targeted Drugs for Breast Cancer Sales Value and Growth Rate (2017-2028)

    • Figure South Africa HER-2 Targeted Drugs for Breast Cancer Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa HER-2 Targeted Drugs for Breast Cancer Sales Value and Growth Rate (2017-2028)

    • Figure Argentina HER-2 Targeted Drugs for Breast Cancer Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina HER-2 Targeted Drugs for Breast Cancer Sales Value and Growth Rate (2017-2028)

    • Table Puma Biotechnology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Puma Biotechnology Product Profiles, Application and Specification

    • Table Puma Biotechnology HER-2 Targeted Drugs for Breast Cancer Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Hengrui Medicine Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Hengrui Medicine Product Profiles, Application and Specification

    • Table Hengrui Medicine HER-2 Targeted Drugs for Breast Cancer Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Hetero Drugs Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Hetero Drugs Product Profiles, Application and Specification

    • Table Hetero Drugs HER-2 Targeted Drugs for Breast Cancer Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Roche Product Profiles, Application and Specification

    • Table Roche HER-2 Targeted Drugs for Breast Cancer Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table CANbridge Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table CANbridge Product Profiles, Application and Specification

    • Table CANbridge HER-2 Targeted Drugs for Breast Cancer Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Product Profiles, Application and Specification

    • Table Novartis HER-2 Targeted Drugs for Breast Cancer Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Product Profiles, Application and Specification

    • Table GlaxoSmithKline HER-2 Targeted Drugs for Breast Cancer Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Beacon Pharmaceuticals Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Beacon Pharmaceuticals Limited Product Profiles, Application and Specification

    • Table Beacon Pharmaceuticals Limited HER-2 Targeted Drugs for Breast Cancer Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Chugai Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Chugai Pharmaceutical Product Profiles, Application and Specification

    • Table Chugai Pharmaceutical HER-2 Targeted Drugs for Breast Cancer Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer HER-2 Targeted Drugs for Breast Cancer Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US